Global veterinary dermatology drugs market is anticipated to grow at a CAGR of 9.2% during the forecast period (2024-2031). The focus of governments and regulatory bodies on animal health and welfare has allowed for investments in the dermatology drugs-based veterinary sector with an emphasis on skin diseases and health problems in animals thereby expanding the growth prospects of the global veterinary dermatology drugs market. Furthermore, the awareness for dermatological care for animals is rising, leading to an increase in the need for efficient treatment methods.
Browse the full report description of “Veterinary Dermatology Drugs Market Size, Share & Trends Analysis Report by Type (Antifungal Drugs, Antibacterial Drugs, and Antiparasitic Drugs), by Animal Type (Companion Animals and Livestock Animals), by Route of Administration (Topical, Oral, and Injectable), Distribution Channel (Hospital Pharmacies, Retail, and E-commerce), and by Indication (Parasitic Infections, Allergic Infections, and Others) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/veterinary-dermatology-drugs-market
For instance, in May 2022, several Indian states experienced a widespread outbreak of Lumpy Skin Disease (LSD) among livestock. LSD is classified as an epizootic rather than a zoonotic illness, caused by the Capripox virus, which shares genetic similarities with the viruses responsible for goat and sheep pox. By October 21st, 2022, approximately 2.4 million animals had been affected by the outbreak, resulting in over 110,000 fatalities.
Additionally, the various strategic decisions of the market players are contributing significantly towards the market growth. For instance, in September 2022, as an illustration, Zoetis finalized the acquisition of Jurox, thereby granting Zoetis access to a significant range of products poised for expanded global reach and bolstering its animal health portfolio with valuable additions.
Market Coverage
• The market number available for – 2023-203
• Base year- 2023
• Forecast period- 2024-2031
• Segment Covered-
o By Type
o By Animal Type
o By Route of Administration
o By Distribution Channel
o By Indication
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Bimeda, Inc., Ceva Sante Animale, Elanco, Merck & Co., Inc., and Zoetis Inc., among others.
Key questions addressed by the report.
Global Veterinary Dermatology Drugs Market Report Segment
By Type
By Animal Type
By Route of Administration
By Distribution Channel
By Indication
Global Veterinary Dermatology Drugs Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/veterinary-dermatology-drugs-market